Guangzhou, March 28th - The First China Green Biomanufacturing Summit (CGBMS) was held in Guangzhou, focusing on exploring new models, technologies, and ideas for applying synthetic biology. The event's highlights were an insight into market trends and discussions on synthetic biology's future. Under the theme "Growth of All Things, Synthesis of the Future," seven academicians, including Gao Fu, Deng Zixin, Yuan Yingjin, Zheng Yuguo, and Song Erwei, shared their latest research and thoughts on synthetic biology. Over 400 guests from the government, academia, and industry gathered to contribute their insights on seizing the new track of synthetic biology.
In recent years, driven by technological breakthroughs and policy support, synthetic biology has experienced remarkable development. It has been widely applied in various fields, including medical and health, green energy, daily chemical and cosmetics, biomaterials, and food consumption. McKinsey data predicts that by 2025, the economic value of synthetic biology and biomanufacturing will reach $100 billion, with 60% of global material production achievable through biomanufacturing.
Gao Fu, academician of the Chinese Academy of Sciences and chairman of the Chinese Society of Biotechnology, stated in his speech that synthetic biology is rapidly advancing towards practical applications and industrialization, presenting historic opportunities and broad prospects. He emphasized that synthetic biology will play a unique role in "dual carbon," biomaterials, bioinformatics, and artificial intelligence. It is a battleground for leading technological nations and holds strategic significance for transforming China's related industries and achieving sustainable green development.
Academicians and industry experts, including Deng Zixin, director of the State Key Laboratory of Microbial Metabolism; Yuan Yingjin, professor at Tianjin University; Zheng Yuguo, professor at Zhejiang University and academician of the Chinese Academy of Engineering, and Song Erwei, director of the Sun Yat-sen Memorial Hospital at Sun Yat-sen University, delivered keynote speeches on topics such as "Leveraging Synthetic Biology for Disruptive Innovations in Health Technology," "Synthesis and Application of Yeast Genomes," "Biomanufacturing: an Advanced Model for Material Conversion," and "Exploration and Future Development of Platform-based Synthetic Biology."
To further deepen research on green biomanufacturing applications represented by synthetic biology and promote the industrial transformation of scientific research achievements, the summit launched the "Innovation Research Platform for Synthetic Biology Applications." It released the "2022 Research Report on Green Applications and Industry Perception of Synthetic Biology in China." This report comprehensively summarizes the development process, opportunities, and challenges of China's synthetic biology industry and selects outstanding cases to promote the healthy and stable development of the industry.
The First China Green Biomanufacturing Summit was jointly organized by Science and Technology Daily and the Chinese Society of Biotechnology, with the support of the People's Government of Guangzhou and the People's Government of Haizhu District, Guangzhou. It was hosted by Tidetron Bioworks (Guangzhou) Co., Ltd.